Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune biomarkers: how well do they serve prognosis in human cancers?
Baxevanis CN, Anastasopoulou EA, Voutsas IF, Papamichail M, Perez SA. Baxevanis CN, et al. Among authors: papamichail m. Expert Rev Mol Diagn. 2015 Jan;15(1):49-59. doi: 10.1586/14737159.2015.965684. Epub 2014 Oct 27. Expert Rev Mol Diagn. 2015. PMID: 25345403 Review.
Cancer immunotherapy.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: papamichail m. Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Crit Rev Clin Lab Sci. 2009. PMID: 19650714 Free article. Review.
Immunologic biomarkers in prostate cancer: the AE37 paradigm.
Baxevanis CN, Papamichail M, Perez SA. Baxevanis CN, et al. Among authors: papamichail m. Hum Vaccin Immunother. 2014;10(5):1244-7. doi: 10.4161/hv.28032. Epub 2014 Feb 19. Hum Vaccin Immunother. 2014. PMID: 24552987 Free PMC article.
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.
Anastasopoulou EA, Voutsas IF, Keramitsoglou T, Gouttefangeas C, Kalbacher H, Thanos A, Papamichail M, Perez SA, Baxevanis CN. Anastasopoulou EA, et al. Among authors: papamichail m. Cancer Immunol Immunother. 2015 Sep;64(9):1123-36. doi: 10.1007/s00262-015-1717-1. Epub 2015 May 31. Cancer Immunol Immunother. 2015. PMID: 26026288 Free PMC article. Clinical Trial.
HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones.
Perez SA, Sotiropoulou PA, Sotiriadou NN, Mamalaki A, Gritzapis AD, Echner H, Voelter W, Pawelec G, Papamichail M, Baxevanis CN. Perez SA, et al. Among authors: papamichail m. Cancer Immunol Immunother. 2002 Jan;50(11):615-24. doi: 10.1007/s002620100225. Epub 2001 Nov 23. Cancer Immunol Immunother. 2002. PMID: 11807625 Free PMC article.
205 results